Harnessing the thymus as an in vivo bioreactor for in vivo generation of naïve CAR T cells.
Targeted cancer therapy with CAR T cell-derived extracellular vesicles.
Nanotechnology Cancer Treatments
Combination of bispecific antibody therapy with NexImmune’s Artificial Immune Modulation (AIM) platform in multiple myeloma and AML.
Targeted cancer therapy using a novel NF-kB inhibitor and a gold nanoparticle-based drug delivery system (collaboration with Stevens Institute of Technology).